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ABSTRACT 
Vataja Kasa (presented by Shushka Kasa, Prasakta Vega, Shirah Shoola, Hrit Shoola, 
Parshwa Shoola, Swara Bheda and Kshamanana) has an increasing prevalence overtime 
due to the external influences such as industrialization, urbanization, environmental 
pollution and population explosion. Since it’s a demanding health concern, Vataja Kasa 
was taken up for the present clinical study and was approximately co-related to 
Tropical Pulmonary Eosinophilia (TPE) which is an immune hyper-responsiveness to 
microfilariae trapped in the lungs, characterised by paroxysmal nocturnal cough, 
breathlessness, wheezing, chest pain, scanty sputum production and eosinophilia. The 
study was conducted with the prime aim of assessing the efficacy of the trial drugs 
Vishwadi Leha and Bharangyadi Leha in the management of Vataja kasa – TPE. The 
Clinical trial included 40 patients of Vataja Kasa categorized into two groups (20 in 
each). In Group A-Vishwadi Leha (3 gms) and in Group B- Bharangyadi Leha (3 gms) 
were administered thrice daily along with quantity sufficient warm water after food for 
30 days. The findings were recorded, assessed and graded accordingly on the 14th and 
30th day. The results were analysed statistically for ‘p’ value using student’s paired t-
test before and after treatment. Significant results (p<0.001) were observed in both 
groups. Comparative study between percentages of improvement in Group A showed 
5% (based on subjective parameters) and 7% (based on objective parameters) more 
improvement than that of Group B. Based on the results, it was concluded that 
Vishwadi Leha has a slightly better result than Bharangyadi Leha in the management of 
Vataja Kasa-TPE.  
KEYWORDS: Vataja Kasa, Vishwadi leha, Bharangyadi leha, Tropical Pulmonary 
Eosinophilia (T.P.E). 
INTRODUCTION 
Breathing involving to and fro movement of 
air through the Pranavaha Srotas, is a normal 
phenomenon and a vital sign indicative of life, the 
normalcy of which is suggestive of good health. Its 
abnormality leads to disease and its cessation leads 
to the death of an individual. This unique sign of life 
is affected by a condition called as Kasa, because of 
the continuous exposure of the respiratory system to 
the external environment affected by industriali-
zation and population explosion, with an influence of 
modern life style leading to the agitation of the 
individual in the routine activities. As a result of Raja 
and Dhuma (dust and smoke), the main cause of 
Pranavaha srotas dusti, have become unavoidable, 
making Kasa the most common disease, where 
Shuska Kasa is a prominent symptom.[1] The scientific 
and systematic description of Kasa termed as cough 
by allied science, is versified in Ayurveda as an 
independent disease entity as well as symptom of 
other diseases. Kasa though seems simple, when 
neglected or mismanaged leads to a disease with 
poor diagnosis.[2] Amongst the 5 major types of 
Kasa[3], Vataja Kasa presenting with Shushka Kasa, 
Shirah Shoola, Parshwa Shoola, Hrit Shoola, Swara 
Bheda, Prasakta Vega, Kshamanana seems to be very 
common condition in the locality. It may be taken as a 
special reference to Tropical Pulmonary Eosinophilia 
(TPE) because of the similarities in the signs and 
symptoms. In 1943, Weingarten first described the 
condition of spasmodic bronchitis, eosinophilic 
leukocytosis and disseminated mottling of both lungs 
as TPE.[4] The syndrome is largely confined to the 
tropics and is particularly endemic in regions of 
Indian subcontinent, South East Asia, South America 
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and Africa. In India, it is mostly found around coastal 
regions from Maharashtra to Kerala and West Bengal 
to Tamil Nadu.[5] Affects male and females in ratio 4:1 
and is rarely seen in children.[6] TPE could result in a 
fair degree of respiratory morbidity if left untreated. 
Treatment consists of Diethylcarbamezine for at least 
3 weeks despite which about 12-25% of patients may 
relapse[7] and also exhibits few common side effects 
such as dizziness, nausea, fever, headache or pain in 
the muscles or joints.[8] Though evaluation works and 
progress have been made in the management of 
Vataja Kasa, there has been very little work done on 
the efficient drugs. In Shamana Chikitsa of Vataja 
Kasa, Lehya are explained to treat effectively. From 
these prospects the present study has been taken to 
evaluate and compare the efficacy of Vishwadi Leha[9] 
and Bharangyadi Leha[10] both containing mostly 
Ushna Virya, Vatahara and Vata Kapha Shamaka 
drugs,[11]  in the management of Vataja Kasa.   
OBJECTIVES 
To compare the efficacy of Vishwadi Leha and 
Bharangyadi Leha in the management of Vataja Kasa 
w.s.r. Tropical Pulmonary Eosinophilia. 
MATERIALS AND METHODS 
40 patients of either sex fulfilling the 
inclusion criteria of Vataja Kasa attending the OPD 
and IPD of A.L.N.Rao Memorial Ayurvedic Medical 
College & Hospital (ALNRMAMC, Koppa), from 
medical camps and other referrals were incidentally 
selected and randomly categorised into 2 groups- 
Group A and Group B with 20 patients each for the 
study. Written consents from the patients were 
obtained before clinical trial. The trial drugs Vishwadi 
Leha and Bharangyadi Leha were prepared in the 
pharmacy of ALNRMAMC, Koppa as per the standard 
method of preparation of Churna Kalpana according 
to AFI guidelines.[12] 
Study Design 
Single blind Randomized Comparative clinical study. 
Inclusion Criteria 
1. Patients diagnosed with Vataja Kasa based on 
classical signs and symptoms of either sex aged 
18 to 60 yrs. 
2. Patients with increased Absolute Eosinophil 
Count (more than 400cells/cumm[13]) will be 
selected. 
Exclusion Criteria 
1. T.P.E with complications/ secondary infections/ 
asthma/ syndrome’s are excluded. Vataja kasa as 
an associated symptom in other system illnesses 
like Bronchial asthma, Pneumonia, other 
Eosinophilic lung diseases are excluded.           
2. Patients with uncontrolled systemic diseases like 
Diabetes Mellitus and Hypertension. 
3. Patients with complication of Kasa i.e. 
Rajayakshma, carcinoma of bronchus, pulmonary 
tuberculosis, pleurisy, pneumonia are excluded.          
4. All the other varieties of Kasa.            
5. Pregnant and lactating women are excluded.  
Assessment Criteria: Criteria for assessment is given in the following table. 
Table 1: Grading system of Vataja Kasa based on subjective and objective parameters 
Subjective Parameters 
S.No. Symptoms Grade 0 Grade 1 Grade 2  Grade 3 
1. Shushka Kasa (dry 
cough) 
No cough 
(during the 
day or 
night) 
Mild (cough for one 
short period during the 
day not interfering with  
daily activities; wake 
once at night due to 
cough) 
Moderate (frequent 
cough not interfering 
with usual day time 
activities; frequent 
waking during night 
due to cough) 
Severe 
(Distressing cough 
most of the day 
and night) 
2. Prasakta Vega 
(paroxysms of dry 
cough) 
No 
paroxysms. 
Mild paroxysms of 
cough /24 hrs. 
Moderate paroxysms 
of cough/ 24 hrs. 
Severe 
(continuous) 
paroxysms of 
cough/ 24hrs.  
3. Shirah Shoola 
(Headache) 
No pain 
Mild (Present only 
during cough) 
Moderate  
(intermittently 
present irrespective  
of cough, not affecting 
routine activities) 
Severe 
(continuously 
present 
irrespective of 
cough affecting the 
daily activities) 
4. Parshwa Shoola 
(Pain in the flanks) 
5. Hrit Shoola (pain in 
the chest) 
6.  Swara Bheda 
(hoarseness in the 
No 
hoarseness 
Mild hoarseness in the 
voice 
Moderate hoarseness 
in the voice. 
Severe hoarseness 
in the voice. 
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voice) in the voice. 
7. Kshamanana (Pallor 
on face) 
No pallor Mild pallor on face Moderate pallor on 
face 
Severe pallor on 
the face. 
Objective Parameter 
S.No Parameters Grade 0 Grade 1 Grade 2 Grade 3 
8. Absolute Eosinophil 
Count (A.E.C) 
400-999 
cu/mm 
1000-1599 cu/mm 1600-2100 cu/mm >2100 cu/mm 
Intervention 
Criteria Group A Group B 
Sample Size 20 20 
Medicine Vishwadi Leha Bharangyadi Leha 
Dose 3 gms, thrice daily, after food 3 gms, thrice daily, after food 
Anupana Ushna Jala (quantity sufficient) Ushna Jala (quantity sufficient) 
Duration 4 weeks 4 weeks 
Follow Up After 2 weeks After 2 weeks 
Pathya Ahara and Vihara were advised to all the subjects. 
Statistical Analysis 
Statistical analysis was carried out using the SPSS (32 bit) software. All the observed data were statistically 
analysed using students paired “t-test”. 
Observation 
Table 2: Incidence based on the presenting symptoms 
Symptoms Trial group A Percentage Trial group B Percentage 
Shushka kasa 20 100 20 100 
Prasakta vega 20 100 20 100 
Shirah shoola 16 80 17 85 
Parshwa shoola 18 90 20 100 
Hrit shoola 4 20 6 30 
Swara bheda 16 80 20 100 
Kshamanana 10 50 11 55 
Amongst 40 patients selected for the clinical trial, 40 (100%) patients were reported to have had Shushka Kasa, 
40 (100%) had Prasakta Vega, 38 (95%) patients had Parshwa Shoola, 36 (90%) patients had Swara Bheda, 
33(82.5%) patients had Shirah Shoola and 22 (55%) patients had Kshamanana. 
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Table 3: Incidence based on A.E.C (cu/mm) 
A.E.C cu/mm Trial group A Percentage Trial group B Percentage 
400-999 20 100 20 100 
1000-1599 0 0 0 0 
1600-2199 0 0 0 0 
Above 2200 0 0 0 0 
All 40 (100%) patients chosen for the clinical trial were reported to have A.E.C (peripheral blood smear) levels 
ranging from 400-999 cu/mm.  
 
RESULTS AND DISCUSSION 
Table 4: Study of total percentage of improvement in subjective parameter of both groups 
Group Total 
Effect on 
Shushka 
kasa 
Total 
Effect on 
Prasakta 
vega 
Total 
Effect on 
Shirah 
shoola 
Total 
Effect on  
Parshwa 
shoola 
Total 
Effect 
on Hrit 
shoola 
Total 
Effect on 
Swara 
bheda 
Total Effect 
on 
Kshamanana 
Grand Total 
Percentage 
of 
parameters 
Group A 97% 100% 100% 100% 100% 100% 100% 99% 
Group B 96% 100% 100% 100% 100% 100% 100% 94% 
Comparative study between percentages of improvement in subjective Parameters of Both Groups 
reveal almost similar results but Group A (Vishwaadi Leha) showed 5% more improvement than that of Group 
B (Bharangyadi Leha). 
Table 5: Comparative study – overall effect on the subjective parameters of treatments in both groups 
Group                               Percentage of Improvement (Number of Patients=40) 
Complete 
Improvement 
(100%) 
Marked 
Improvement 
(76-99%) 
Moderate 
Improvement 
(51-75%) 
Average 
Improvement 
(26-50%) 
Below Average 
Improvement 
(1-25%) 
No 
Change 
(0%) 
Group A 18 2 0 0 0 0 
Group B 18 2 0 0 0 0 
After the completion of 4 week course of treatment in the two groups the overall assessment of the 
patients was made as shown in the table above. The analysis revealed 18 patients from Group A and 18 patients 
from Group B had 100% relief from the symptoms of Vataja Kasa. 2 patients from Group A and 2 patients from 
Group B showed marked improvement while moderate improvement was seen in 0 patients in Group A and 0 
patients in Group B. Average improvement was seen in 0 patients in Group A and in 0 patients in Group B. 
Meanwhile 0 patients had shown below average improvement or no change from both Groups. 
From the above study it is also clear that the total improvement in the both groups is almost similar. 
Table 6: Study of total percentage of improvement in objective parameter of both groups 
Group Total effect On A.E.C (cu/mm) Grand Total percentage parameter 
Group A 47% 47% 
Group B 40%  40% 
0
5
10
15
20
25
400-999cu/mm 1000-1599cu/mm 1600-2199cu/mm >2200cu/mm
N
O
. O
F
 P
A
T
IE
N
T
S
A.E.C cu/mm
Illustration No.2- showing the incidence Of A.E.C
GROUP A GROUP B
 Sindhu.C.V et al. Efficacy of Vishwadi Leha and Bharangydi Leha in the Management of Vataja Kasa  
     Available online at: http://ijapr.in  15 
 Comparative study between percentages of improvement in Objective Parameters of Both Groups 
reveals almost similar results but Group A (Vishwaadi Leha) had shown 7% more in total improvement than 
that of Group B (Bharangyadi Leha). 
Table 7: Comparative study –overall improvement of both groups in treatment of A.E.C (cu/mm) 
Group                               Percentage of Improvement (Number of Patients=40) 
Complete 
Improvement 
(100%) 
Marked 
Improvement 
(76-99%) 
Moderate 
Improvement 
(51-75%) 
Average 
Improvement 
(26-50%) 
Below Average 
Improvement 
(1-25%) 
No Change 
(0%) 
Group A 0 0 8 10 2 0 
Group B 0 0 7 9 4 0 
After the completion of 4 week course of treatment in the two groups the overall assessment of the patients 
was made as shown in the table above. The analysis revealed 8 patients from Group A and 7 patients from 
Group B had Moderate improvement in normalizing Absolute Eosinophil Count. 0 patients in both Group A and 
Group B showed 100% improvement while marked improvement was seen in 0 patients in Group A and 0 
patients in Group B.  
Average improvement was noticed in 10 patients in Group A and 9 patients in Group B.2 patients in Group A 
and 4 patients from Group B had shown below average improvement meanwhile 0 patients from both groups 
had shown No change. 
Group A Shown a total of 47% improvement in the effect on Absolute Eosinophil Count while Group B shown a 
total of 40% improvement in the same. 
Table 8: Statistical Analysis on the total effect of both groups 
Statistical 
Analysis 
Group A Group B 
Parameters 
Mean 
(difference) 
SD 
(difference) 
SEM T value P value 
Mean 
(difference) 
SD 
(difference) 
SEM T value P value 
Shushka Kasa 2.750 0.444 0.099 27.683 P<0.001 2.800 0.523 0.117 23.936 P<0.001 
Prasakta 
Vega 
2.550 0.510 0.114 22.342 P<0.001 2.450 0.605 0.135 18.116 P<0.001 
Hrit Shoola 0.200 0.410 0.0918 2.179 P=0.042 0.300 0.470 0.105 2.854 P=0.010 
Parshwa 
Shoola 
1.500 0.688 0.154 9.747 P<0.001 2.000 0.649 0.145 13.784 P<0.001 
Shirah Shoola 1.550 0.945 0.211 7.339 P<0.001 1.250 0.786 0.176 7.109 P<0.001 
Swarabheda 1.250 0.786 0.176 7.109 P<0.001 1.250 0.444 0.0993 12.583 P<0.001 
Kshamanana 0.500 0.513 0.115 4.359 P<0.001 0.550 0.510 0.114 4.819 P<0.001 
A.E.C cu/mm 270.300 108.069 24.165 11.186 P<0.001 242.500 122.900 27.481 8.824 P<0.001 
Statistically, the results obtained regarding the subjective parameters is highly significant (p<0.001) in 
both groups with 100% relief in symptoms such as Prasakta Vega, Hrit Shoola, Parshwa Shoola, Shirah Shoola, 
Swarabheda and Kshamanana whereas the parameter Shuskha Kasa had a relief of 97% in Group A and 96% 
relief in Group B. Overall, 18 subjects from each Group (A & B) showed complete relief (100%) and 2 subjects 
from each Group A & B showed marked improvement (76-99%). 
Likewise, the results obtained regarding the parameter A.E.C (cu/mm) is significant (p <0.001) in both 
groups i.e. in Group A, 8 subjects had moderate improvement (51-75%) and 10 patients showed average 
improvement (26-50%) whereas in Group B, 7subjects had moderate improvement (51-75%) and 9 patients 
showed average improvement (26-50%). 
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Table 9: Comparative Statistical Analysis between two trial groups 
Effect on 
Parameters 
Mean 
(difference) 
SD 
(difference) 
SEM T value P value 
Shushka Kasa 0.050 0.079 0.0177 0.326 P=0.746 
Prasakta Vega 0.100 0.095 0.021 0.565 P=0.575 
Hrit Shoola 0.100 0.060 0.0132 0.0717 P=0.478 
Parshwa Shoola 0.500 0.039 0.009 2.364 P=0.023 
Shirah Shoola 0.300 0.159 0.035 1.092 P=0.282 
Swarabheda 0.000 0.324 0.0767 0.000 P=1.000 
Kshamanana 0.050 0.003 0.001 0.309 P=0.759 
A.E.C cu/mm 27.800 14.831 3.316 0.760 P=0.452 
Comparative statistical study between trial 
Group A and trial Group B, in the effect on Shushka 
Kasa, Prasakta Vega, Hrit Shoola, Parshwa Shoola, 
Shirah Shoola, Swarabheda, Kshamanana and A.E.C 
cu/mm shows an insignificant statistical difference. 
From this, it can be understood that both groups have 
almost similar actions on the selected parameters for 
conducting the trial. 
DISCUSSION ON RESULTS 
Shushka Kasa: The Rooksha Guna of Vata creates 
Shushkata in the concerned area and Chala Guna of 
Vata causes repeated bouts of cough resulting in 
dryness in mouth, throat, chest and head regions 
which in turn causes Shushkata. 
This Shushkata can be rectified by Ushna Veerya and 
Madhura Vipaka of the drug. The specific Doshahara 
Karma i.e., Kasahara property helps to pacify Shushka 
Kasa.  
Prasakta vega: Prasakta Vega is Satata Vega or 
persistent cough, which occurs due to the increased 
stimulation of Vata Nadis by the Chala Guna of Vayu. 
This Chala Guna of Vayu in turn causes Shushkata in 
the Urah and Kanta Pradesha.  
This Shushkata can be rectified by Ushna 
Veerya and Madhura Vipaka of the drugs. The specific 
Doshahara Karma i.e., Kasahara property helps to 
pacify Shushkata and reduce the bouts of cough.  
Shirah shoola: The Prana Vayu situated in the Shirah 
Pradesha gets vitiated and obstructs the Srotas in the 
concerned area. This Marghavarodha affects the 
Chala Guna of Vayu leading to an increased pressure 
inside the Srotas. This in turn causes the contraction 
of muscles in the Shirah Pradesha during the act of 
coughing. The neuro-muscular irritability resulting 
due to repeated and excessive contraction-relaxation 
of the muscles in the head region and the increased 
intra cranial pressure produced during the act of 
cough leads to manifestation of pain in the head 
region. 
Laghu- Snigdha Gunas, Ushna Veerya and Madhura 
Vipaka of the trial drugs help in Kasaharana. 
Whereas, Ushna Veerya, Katu-Tikta-Kashaya Rasa and 
Tikshna Guna of the trial drugs relieves the Avarodha. 
Parshwa shoola: When Prana Vata and Udana Vata 
gets vitiated, it dries out the Shleshma present in the 
lungs, causing it to dry up and clog the lungs. This 
leads to Margavarodha to Vayu Sanchara. Obstructed 
Vayu then blocks the Strotas in the chest region. Thus 
increased pressure in the lungs leads to forceful 
contraction of the muscles in the chest region for the 
forceful expulsion of Vayu resulting in cough. This 
repeated contraction and relaxation of muscles in the 
chest leads to stabbing like pain in the flank region. 
Parshwa Shoola may also result as a complication of 
cough i.e. due to fracture of a rib. 
Ushna Veerya, Tikshna Guna and Katu-Tikta 
Rasa present in the trial drug help in clearing out the 
Margavarodha and clears out the Kapha. Meanwhile 
Ushna Veerya and Madhura Vipaka also present in the 
trial drugs help in pacifying the Prakupita Vata.  
Hrit shoola: The obstruction to the movement of 
Vayu resulting in increased pressure leads to 
stabbing like pain in the chest region. The sudden 
excessive contraction and relaxation of muscles in 
the chest during the act of cough which is dry and 
paroxysmal leads to Hrit Shoola. 
Ushna Veerya, Madhura Vipaka and the 
Rasayana property present in the trial drugs help in 
pacifying the vitiated Vata.  The drugs in the trial 
group has Kasahara, Doshaharakarma and Vatahara 
property which includes analgesic, anti-histaminic, 
anti-oxidant and anti-spasmodic effects helping in 
relieving Hrit Shoola. 
Swara Bheda: Swarabheda is a condition resulted 
due to the vitiation of Udana Vayu. This leads to an 
increase in the stimulation of recurrent laryngeal 
nerve as a result on increase in vibration of vocal 
cords present in the larynx and also due to excessive 
and frequent stimulation of concerned nerve causes 
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impairment in producing sound resembling a broken 
bronze vessel.  
The trial drugs possess Ushna Veerya, 
Madhura Vipaka, Kasahara- DipanaKarma along with 
the Rasayana property which helps in pacifying the 
vitiated Vayu simultaneously soothning the mucus 
membrane of the throat region. 
Kshamanana: Kshamana refers to lusterless face 
(Shushka Mukha Vatena Shoshannath). Due to 
Ojakshaya DhatuKshaya and Bala Kshaya which are 
already present in this disease are held responsible 
in lusterless face. Increase in Eosinophilic count in 
peripheral blood in order to activate defense 
mechanism, MBP (Major Basic Protein) present in the 
Eosinophils are utilized to act against the invading 
organism. This increased utility of proteins leads to a 
lustreless face. 
Madhura Vipaka, Snigdha Guna and the 
Rasayana Karma of the trial drugs help in relieving 
the symptom. The anti-oxidant and anti-histaminic 
properties of the drug included under Vata Shamaka 
Gunas are also responsible for bringing back luster to 
the face.  
A.E.C cu/mm: In group A, 8 patients had moderate 
improvement ranging between 51-75%, 10 patients 
had average improvement ranging between 26-50% 
and 2 patients had below average improvement 
ranging between 1-25%. This was probably due to 
Vata Shamaka and Kasahara properties of Vishwadi 
Leha. 
In group B, 7 patients had moderate 
improvement ranging between 51-75%, 9 patients 
had average improvement ranging between 26-50% 
and 4 patients had below average improvement 
ranging between 1-25%. This was probably due to 
Vata Shamaka and Kasahara properties of 
Bharangyadi Leha. 
From the above results, it can be observed 
that Vishwadi Leha possesses slightly better (7%) 
results than Bharangyadi Leha. 
CONCLUSION 
In the present study it is observed that both 
Vishwadi Leha and Bharangyadi Leha effectively 
reduced the signs and symptoms of Vataja Kasa, with 
Vishwadi Leha showing slightly better (5%) results 
than Bharangyadi Leha. Similarly, with regards to 
Absolute Eosinophilic Count, Vishwadi Leha showed 
slightly better (7%) results compared to Bharangyadi 
Leha. It was observed that in both the groups, 
patients were relived of symptoms of Vataja Kasa 
within 30 days after the commencement of 
treatment.   
Statistically, the results obtained regarding 
the subjective parameters is highly significant 
(p<0.001) in both groups with 100% relief in 
symptoms such as Prasakta Vega, Hrit Shoola, 
Parshwa Shoola, Shirah Shoola, Swarabheda and 
Kshamanana whereas the parameter Shuskha Kasa 
had a relief of 97% in Group A and 96% relief in 
Group B. Overall, 18 subjects from each Group (A & 
B) showed complete relief (100%) and 2 subjects 
from each Group A & B showed marked improvement 
(76-99%). 
Likewise, the results obtained regarding the 
parameter A.E.C (cu/mm) is significant (p <0.001) in 
both groups i.e. in Group A, 8 subjects had moderate 
improvement (51-75%) and 10 patients showed 
average improvement (26-50%) whereas in Group B, 
7subjects had moderate improvement (51-75%) and 
9 patients showed average improvement (26-50%). 
It is clear that the total improvement in the both 
groups are almost similar, even though a slightly 
better percentage of improvement can be noticed in 
the Group A where Vishwaadi Leha was used than 
Group B where the Bharangyadi Leha was put into 
trial. Both Vishwadi Leha as well as Bharangyadi Leha 
are effective in the management of Vataja kasa.  
 The sample size was not enough to draw 
generalized conclusion. Study should be done by 
increasing the sample size for getting a generalized 
conclusion. The study of this work is restricted to a 
particular geographical area. Multi-centric study has 
to be conducted to re-establish the efficacy, including 
the people of different geographical distribution.  
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